skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 119624 Find in a Library
Title: Drug Testing in the Pharmaceutical Industry: Its Faults and Its Victims (From Crime and Its Victims: International Research and Public Policy Issues, P 257-266, 1989, Emilio C Viano, ed. -- See NCJ-119600)
Author(s): F J Henry
Date Published: 1989
Page Count: 10
Sponsoring Agency: Hemisphere Publishing Corp
Bristol, PA 19007
Sale Source: Hemisphere Publishing Corp
1900 Frost Road
Suite 101
Bristol, PA 19007
United States of America
Type: Survey
Language: English
Country: United States of America
Annotation: Because the entire drug industry is directed toward profit, the testing of drugs is oriented not so much to assess their efficacy and safety as to win government approval for their marketing.
Abstract: One of the necessary steps involved in bringing a new drug to market is an investigation into its effectiveness and possible harmful side effects. This research is performed in two basic stages: animal studies and the clinical stage of experimentation involving human subjects. Preclinical drug testing is based on a number of assumptions: (1) if a drug is safe for two other species it is also safe for humans, and (2) humans are approximately as sensitive to the drug being tested as the animal species used in the test. The weaknesses of these assumptions means that even the most careful drug testing is far from perfect. There are a number of ways of obtaining favorable results in the preclinical safety testing of drugs without outright falsification. These include using too few animals in the experiment so that no statistically significant result appears, using modern microsurgery to alter results, and the manner of selection of the control group. Bibliography
Main Term(s): Pharmacy crimes
Index Term(s): Controlled Substances; Drug manufacturing; Drug research
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.